Molecular Formula | C5H14N4O7S |
Molar Mass | 274.25 |
Melting Point | 160-165°C (dec.) |
Boling Point | 574°C at 760mmHg |
Solubility | Soluble in water and ethanol |
Appearance | White powder |
Color | white |
BRN | 6121291 |
Storage Condition | 2-8°C |
Sensitive | Air `sensitive` seal |
MDL | MFCD00012618 |
In vitro study | L-Canavanine sulfate (L-CAV) causes only a limited degree of cytotoxicity in HeLa, Hep G2, and SK-HEP-1 cells when given alone in arginine-rich media with IC 50 values ranging from 5 to 10 mM. In HaCaT keratinocyte cell line, IC 50 of L-Canavanine sulfate exceeds the concentration of 10 mM, indicating low cytotoxicity in normal cells in vitro . In arginine-free media, IC 50 of L-Canavanine sulfate in HeLa, Hep G2, and SK-HEP-1 cells are 0.21±0.04; 0.64±0.16; and 1.18±0.14 mM, respectively. L-Canavanine sulfate, which is hardly toxic alone, potentiates the cytotoxicity of vinblastine (VIN) and paclitaxel (PTX) in HeLa and hepatocellular carcinoma cells. |
In vivo study | Administration of L-Canavanine sulfate (100 mg/kg) produces a moderate increase in mean arterial pressure of 20 mm Hg, returns blood pressure to near basal levels and completely attenuates the lipopolysaccharide-induced hypotension. All, but one, endotoxaemic rats dosed with L-Canavanine sulfate (100 mg/kg) survive for 6 h post lipopolysaccharide, after which time the experiment is terminated (n=7). L-canavanine inhibits DNA synthesis by Li 210 cells in vivo and significantly increases the lifespan of animals bearing the Li 210 leukemia. An optimal dose of 18 g/kg produces a peak increase in lifespan of 44%. The therapeutic dose range is narrow, and a dose of 24 g/kg causes death due to drug toxicity. |
Hazard Symbols | Xn - Harmful |
Risk Codes | R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S36 - Wear suitable protective clothing. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
UN IDs | 2811 |
WGK Germany | 3 |
biological activity | L-Canavanine sulfate are selective inhibitors of inducible NO synthase (NO synthase). |
target | NO synthase |
in vitro study | L-Canavanine sulfate (L-CAV) cause only a limited degree of cytotoxicity in HeLa, Hep G2, and SK-HEP-1 cells when given alone in arginine-rich media with IC 50 values ranging from 5 to 10 mM. In HaCaT keratinocyte cell line, IC 50 of L-Canavanine sulfate exceeds the concentration of 10 mM, indicating low cytotoxicity in normal cells in vitro . In arginine-free media, IC 50 of L-Canavanine sulfate in HeLa, Hep G2, and SK-HEP-1 cells are 0.21±0.04; 0.64±0.16; And 1.18±0.14 mM, respectively. L-Canavanine sulfate, which is hard toxic alone, potentiates the cytotoxicity of vinblastine (VIN) and paclitaxel (PTX) in HeLa and hepatocellular carcinoma cells. |
in vivo study | Administration of L-Canavanine sulfate (100 mg/kg) produces a moderate increase in mean arterial pressure of 20mm Hg, returns blood pressure to near basic levels and completely attenuates the lipopolysaccharide-induced hypotension. All, but one, endotoxaemic with L-Canavanine sulfate (100 mg/kg) survive for 6 h post lipopolysaccharide, after which time the experiment is terminated (n = 7). L-canavanine inhibits DNA synthesis by Li 210 cells in vivo and significantly increases the lifespan of animals bearing the Li 210 leukemia. an optimal dose of 18 g/kg produces a peak increase in lifespan of 44%. the therapeutic dose range is narrow, and a dose of 24 g/kg cause death due to drug toxicity. |
EPA chemical information | information is: offered by ofmpub.epa.gov (external link) |